Gastric Volvulus Treatment Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the gastric volvulus treatment market right now?
The size of the gastric volvulus treatment market has seen robust growth lately. The market, which is expected to rise from $27.36 billion in 2024 to $28.95 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 5.8%. Factors contributing to the historic growth include enhancements in surgical methods, advancement in diagnostic technologies, education and awareness programs, an increase in minimally invasive procedures, and research and clinical trials.
How fast Is the gastric volvulus treatment market expected to grow, and what’s its future value?
The market size for gastric volvulus treatment is projected to experience significant growth over the coming years. It is anticipated to reach $37.48 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This projected growth during the forecast period can be associated with regulatory modifications and approvals, advancements in surgical procedures, increase in the elderly population, personalized treatment plans, and the use of cutting-edge imaging techniques. Key trends expected to influence this market during the same period are minimally invasive surgical procedures, heightened public awareness and early intervention, research advancements in treatment modalities, cooperative medical practices, and tailor-made treatment strategies.
Get your gastric volvulus treatment market report here!
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
What are the leading drivers of growth in the gastric volvulus treatment market?
The anticipated increase in the population of individuals aged 65 and above is projected to stimulate the growth of the gastric volvulus treatment market. Gastric volvulus is more common in older adults, specifically those who are over 50 years of age, due to their reduced immunity and advanced age. The surge in this age group is thus predicted to accelerate the market’s advancement. For example, data from the US non-profit, Population Reference Bureau (PRB), from January 2024 forecasted that the population of Americans aged 65 and older would surge from 58 million in 2022 to 82 million in 2050, showing a rise of 47%. In the same span, their fraction of the total population is predicted to rise from 17% to 23%. Consequently, the burgeoning senior citizen populace is fueling the upsurge of the gastric volvulus treatment market.
What are the key segments defining the gastric volvulus treatment market?
The gastric volvulus treatment market covered in this report is segmented –
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
Who are the key players steering the development of the gastric volvulus treatment market?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc
What emerging trends are influencing the growth of the gastric volvulus treatment market?
One significant trend emerging in the gastric volvulus treatment market is product innovation. In order to maintain their market standing, major players are developing and launching new products. For instance, Pfizer Inc., an American pharmaceutical corporation, declared in October 2023 that VELSIPITY (etrasimod) had received approval from the U.S. Food and Drug Administration (FDA). This FDA-approved, once-daily oral drug, VELSIPITY, is a sphingosine-1-phosphate (S1P) receptor activator designed for those suffering from moderate to severe active ulcerative colitis. The recommended dosage of VELSIPITY is 2mg and it allows adults dealing with moderate to severe active UC to reach a steroid-free resolution via an oral, once-daily pill that possesses a favourable benefit-risk relationship. This FDA approval of VELSIPITY represents a significant milestone for UC patients in need of new treatments, gearing up to start advanced therapy for their chronic condition.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382
Which regions are most influential in expanding the gastric volvulus treatment market?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Conjugated Monoclonal Antibodies Global Market Report 2024
Anemia And Other Blood Disorder Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
